Tholeti Prathima, Uppangala Shubhashree, Kalthur Guruprasad, Adiga Satish Kumar
P Tholeti, Department of Reproductive Science, Manipal Academy of Higher Education, Manipal, India.
S Uppangala, Department of Reproductive Science, Manipal Academy of Higher Education, Manipal, India.
Reprod Fertil. 2024 Oct 1;5(4). doi: 10.1530/RAF-24-0079.
Historically, infertility has been stigmatized in the Indian society, primarily due to societal norms that equate marriage with procreation. In twentieth century, India focused primarily on over-fertility in its family planning programs, with little attention given to the complexities of infertility. The introduction of Assisted Reproductive Technology (ART) in the late 1970s made a global revolution, including in India, offering hope to infertile couples. Despite a significant rise in ART clinics offering a wide range of treatment options in the recent years, challenges remain, particularly regarding the affordability. In India, ART is typically dominated by the private sector as government support remains limited. Efforts to standardize ART practices, including the establishment of the National ART & Surrogacy Registry and ART act aim to regulate, improve outcomes and curb unethical practice. Despite these advancements, the high cost of treatment cycles and lack of insurance coverage limit many couples' ability to undergo fertility treatment. Addressing these issues requires a multifaceted approach, including policy reform, increased public awareness, and the development of affordable treatment options to ensure broader access to reproductive care across India.
从历史上看,在印度社会,不孕一直受到污名化,主要是因为社会规范将婚姻与生育等同起来。在20世纪,印度在其计划生育项目中主要关注生育过多的问题,很少关注不孕的复杂性。20世纪70年代末辅助生殖技术(ART)的引入引发了一场全球革命,在印度也是如此,为不孕夫妇带来了希望。尽管近年来提供广泛治疗选择的ART诊所数量大幅增加,但挑战依然存在,尤其是在可负担性方面。在印度,ART领域通常由私营部门主导,因为政府支持仍然有限。规范ART实践的努力,包括建立国家ART与代孕登记处以及ART法案,旨在进行监管、改善治疗结果并遏制不道德行为。尽管取得了这些进展,但治疗周期的高昂成本和缺乏保险覆盖限制了许多夫妇接受生育治疗的能力。解决这些问题需要多方面的方法,包括政策改革、提高公众意识以及开发可负担的治疗选择,以确保印度各地有更广泛的机会获得生殖保健服务。